Waters Corporation Chief Financial Officer to Stand Down
Waters Corporation (Massachusetts, USA) has announced that Chief Financial Officer John Ornell intends to move to a reduced workload and resign from 1 February 2014. Ornell will continue to work for the company in an advisory capacity on a part-time basis. Eugene G. Cassis, currently Corporate Vice President of Worldwide Business Development and Investor Relations, will serve as the company?s interim Chief Financial Officer from 1 February 2014.
Waters Corporation (Massachusetts, USA) has announced that Chief Financial Officer John Ornell intends to move to a reduced workload and resign from 1 February 2014. Ornell will continue to work for the company in an advisory capacity on a part-time basis. Eugene G. Cassis, currently Corporate Vice President of Worldwide Business Development and Investor Relations, will serve as the company’s interim Chief Financial Officer from 1 February 2014.
Douglas A. Berthiaume, Chairman and Chief Executive Officer, said: “I’d like to thank John for his dedication to Waters over the past 23 years and for his many contributions as the company’s CFO for the past 12 years. I am pleased that Gene Cassis will serve the company as interim CFO. Gene brings a wealth of relevant experience and a record of success in key leadership positions while already enjoying close working relationships with our investor base, our banking contacts, and with Waters Executive Committee.”
For more information please visit:
Best of the Week: Food Analysis, Chemical Migration in Plastic Bottles, STEM Researcher of the Year
December 20th 2024Top articles published this week include the launch of our “From Lab to Table” content series, a Q&A interview about using liquid chromatography–high-resolution mass spectrometry (LC–HRMS) to assess chemical hazards in plastic bottles, and a piece recognizing Brett Paull for being named Tasmanian STEM Researcher of the Year.
Using LC-MS/MS to Measure Testosterone in Dried Blood Spots
December 19th 2024Testosterone measurements are typically performed using serum or plasma, but this presents several logistical challenges, especially for sample collection, storage, and transport. In a recently published article, Yehudah Gruenstein of the University of Miami explored key insights gained from dried blood spot assay validation for testosterone measurement.
Determination of Pharmaceuticals by Capillary HPLC-MS/MS (Dec 2024)
December 19th 2024This application note demonstrates the use of a compact portable capillary liquid chromatograph, the Axcend Focus LC, coupled to an Agilent Ultivo triple quadrupole mass spectrometer for quantitative analysis of pharmaceutical drugs in model aqueous samples.
